Get the Stockscreener App
0.9352
2.84%
0.0258
After Hours:
.93
-0.0052
-0.56%
Elutia Inc stock is traded at $0.9352, with a volume of 351.37K.
It is up +2.84% in the last 24 hours and up +6.27% over the past month.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$0.9094
Open:
$0.91
24h Volume:
351.37K
Relative Volume:
1.66
Market Cap:
$35.61M
Revenue:
$24.38M
Net Income/Loss:
$-53.95M
P/E Ratio:
-0.3786
EPS:
-2.47
Net Cash Flow:
$-23.31M
1W Performance:
+3.91%
1M Performance:
+6.27%
6M Performance:
-54.16%
1Y Performance:
-70.68%
1-Day Range:
$0.91
$0.98
1-Week Range:
$0.8821
$0.98
52-Week Range:
$0.85
$5.12
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.9352 | 38.55M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Real time breakdown of Elutia Inc. stock performanceBond Market & Stepwise Entry/Exit Trade Alerts - newser.com
How Elutia Inc. stock reacts to inflationary pressuresGold Moves & Risk Managed Investment Signals - newser.com
Forecasting Elutia Inc. price range with options data2025 Pullback Review & AI Driven Stock Reports - newser.com
Is Elutia Inc. reversing from oversold territory2025 Top Gainers & Verified Entry Point Signals - newser.com
Analyzing recovery setups for Elutia Inc. investors2025 Volatility Report & Fast Entry and Exit Trade Plans - newser.com
Is Elutia Inc. showing signs of accumulation2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
How rising interest rates impact Elutia Inc. stock2025 Market Overview & Technical Confirmation Alerts - newser.com
Visual trend scoring systems applied to Elutia Inc.2025 Volatility Report & Expert Curated Trade Setups - newser.com
Is Elutia Inc. building a consolidation baseJuly 2025 Macro Moves & AI Forecasted Stock Moves - newser.com
Why Elutia Inc. stock appeals to analystsProduct Launch & Free Community Supported Trade Ideas - newser.com
Is Elutia Inc. stock positioned for digital transformationQuarterly Investment Review & Advanced Technical Signal Analysis - newser.com
Is Elutia Inc. stock a buy before product launchesShare Buyback & Consistent Return Strategy Ideas - newser.com
What sentiment indicators say about Elutia Inc. stock2025 EndofYear Setup & Stock Portfolio Risk Control - newser.com
Will Elutia Inc. stock outperform international peersQuarterly Profit Summary & Long-Term Safe Investment Ideas - newser.com
How Elutia Inc. stock benefits from global expansion2025 Winners & Losers & High Win Rate Trade Tips - newser.com
How Elutia Inc. stock responds to policy changesPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
How Elutia Inc. stock performs in high volatility marketsEarnings Overview Report & Low Drawdown Trading Techniques - newser.com
How Elutia Inc. stock performs during Fed tightening cyclesEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
How to use a screener to detect Elutia Inc. breakoutsLayoff News & Daily Growth Stock Investment Tips - newser.com
What candlestick patterns are forming on Elutia Inc.July 2025 Market Mood & Real-Time Buy Signal Notifications - newser.com
Trend analysis for Elutia Inc. this weekWeekly Trade Analysis & Verified Momentum Watchlists - newser.com
Live market analysis of Elutia Inc.2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
How Analyst Views Are Shifting as Elutia Refocuses After Its BioEnvelope Sale - Yahoo Finance
Why analysts upgrade Elutia Inc. stockWeekly Profit Recap & AI Optimized Trade Strategies - newser.com
Chart overlay techniques for tracking Elutia Inc.Earnings Trend Report & Weekly Stock Breakout Alerts - newser.com
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):